Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine
Open Access
- 20 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e66543
Abstract
The effect of mild chronic renal failure (CRF) induced by 4/6-nephrectomy (4/6NX) on central neuronal activations was investigated by c-Fos immunohistochemistry staining and compared to sham-operated rats. In the 4/6 NX rats also the effect of the angiotensin receptor blocker, losartan, and the central sympatholyticum moxonidine was studied for two months. In serial brain sections Fos-immunoreactive neurons were localized and classified semiquantitatively. In 37 brain areas/nuclei several neurons with different functional properties were strongly affected in 4/6NX. It elicited a moderate to high Fos-activity in areas responsible for the monoaminergic innervation of the cerebral cortex, the limbic system, the thalamus and hypothalamus (e.g. noradrenergic neurons of the locus coeruleus, serotonergic neurons in dorsal raphe, histaminergic neurons in the tuberomamillary nucleus). Other monoaminergic cell groups (A5 noradrenaline, C1 adrenaline, medullary raphe serotonin neurons) and neurons in the hypothalamic paraventricular nucleus (innervating the sympathetic preganglionic neurons and affecting the peripheral sympathetic outflow) did not show Fos-activity. Stress- and pain-sensitive cortical/subcortical areas, neurons in the limbic system, the hypothalamus and the circumventricular organs were also affected by 4/6NX. Administration of losartan and more strongly moxonidine modulated most effects and particularly inhibited Fos-activity in locus coeruleus neurons. In conclusion, 4/6NX elicits high activity in central sympathetic, stress- and pain-related brain areas as well as in the limbic system, which can be ameliorated by losartan and particularly by moxonidine. These changes indicate a high sensitivity of CNS in initial stages of CKD which could be causative in clinical disturbances.Keywords
This publication has 99 references indexed in Scilit:
- Kidney Dysfunction and Cognitive Decline in WomenClinical Journal of the American Society of Nephrology, 2012
- Albuminuria, Kidney Function, and the Incidence of Cognitive Impairment Among Adults in the United StatesAmerican Journal of Kidney Diseases, 2011
- Invited Commentary: Albuminuria and Microvascular Disease of the Brain--A Shared PathophysiologyAmerican Journal of Epidemiology, 2010
- Kidney function is associated with the rate of cognitive decline in the elderlyNeurology, 2009
- Association of Plasma ADMA Levels With MRI Markers of Vascular Brain InjuryStroke, 2009
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With HypertensionArchives of internal medicine (1960), 2009
- Chronic kidney disease, creatinine and cognitive functioningNephrology Dialysis Transplantation, 2009
- Albuminuria, Cognitive Functioning, and White Matter Hyperintensities in Homebound EldersAmerican Journal of Kidney Diseases, 2009
- Biomarkers and Health-Related Quality of Life in End-Stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2008
- What is new in uremic toxicity?Pediatric Nephrology, 2008